Corrigendum to: Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer: Small cell lung cancer MALDI MS (Pathology International, (2012), 62, 1, (28-35), 10.1111/j.1440-1827.2011.02783.x);Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer

Pathology International

Volumn 62, Issue 1, 2012, Pages 28-35

  Lee, Hee Seok ^a   Park, Jun Won ^a   Chertov, Oleg ^b   Colantonio, Simona ^b   Simpson, John T ^b   Fivash, Matthew J ^c   Yoo, Chong Woo ^a   Lee, Geon Kook ^a   Zo, Jae Ill ^a   Kim, Heung Tae ^a   Kim, Hark Kyun ^a  

^a National Cancer Center   (South Korea)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Calcyclin; Cancer; Lung; Mass spectrometry; Small cell

Indexed keywords

CALCYCLIN; SINAPIC ACID;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; ROBOTICS; STATISTICAL SIGNIFICANCE;

EID: 84155174708     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12111     Document Type: Erratum

References (25)

1. Jemal A, Murray T, Ward E etal. Cancer statistics. CA Cancer J Clin 2005; 55: 10-30.
2. Schneider J. Early detection of lung cancers - Comparison of computed tomography, cytology and fuzzy-based tumor markers panels. Cancer Biomark 2010; 6(3-4): 149-62.
3. Yanagisawa K, Shyr Y, Xu BJ etal. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003; 362: 433-9.
4. Kim HK, Reyzer ML, Choi IJ etal. Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. J Proteome Res 2010; 9: 4123-30.
5. Cho NH, Koh ES, Lee DW etal. Comparative proteomics of pulmonary tumors with neuroendocrine differentiation. J Proteome Res 2006; 5(3): 643-50.
6. Jeong HC, Kim GI, Cho SH etal. Proteomic analysis of human small cell lung cancer tissues: Up-regulation of coactosin-like protein-1. J Proteome Res 2011; 10(1): 269-76.
7. Schneider J. Tumor markers in detection of lung cancer. Adv Clin Chem 2006; 42: 1-41.
8. Ma PC, Blaszkowsky L, Bharti A etal. Circulating tumor cells and serum tumor biomarkers in small cell lung cancer. Anticancer Res 2003; 23(1A): 49-62.
9. Schwartz SA, Reyzer ML, Caprioli RM etal. Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: Practical aspects of sample preparation. J Mass Spectrom 2003; 38: 699-708.
10. Aerni HR, Cornett DS, Caprioli RM. Automated acoustic matrix deposition for MALDI sample preparation. Anal Chem 2006; 78: 827-34.
11. Simon R, Lam A, Li MC etal. Analysis of gene expression data using BRB-Array Tools. Cancer Inf 2007; 2: 11-7.
12. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E etal. Molecular alterations in pancreatic carcinoma: Expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003; 201: 63-74.
13. Ishii A, Suzuki M, Satomi K etal. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression. Pathol Int 2009; 59(9): 623-30.
14. Mok TS, Wu YL, Thongprasert S etal. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomas. N Engl J Med 2009; 361: 947-57.
15. Hirsch FR, Speafico A, Novello S etal. The prognostic and predictive role of histology in advanced non-small cell lung cancer: A literature review. J Thorac Oncol 2008; 3: 1468-81.
16. Shah A, Singh H, Sachdev V etal. Differential serum level of specific haptoglobin isoforms in small cell lung cancer. Curr Proteomics 2010; 7(1): 49-65.
17. Han H, Liu Q, Yu J etal. Detection and significance of serum protein markers of small-cell lung cancer. J Clin Lab Anal 2008; 22(2): 131-7.
18. Ziv T, Barnea E, Segal H etal. Comparative proteomics of small cell lung carcinoma. Cancer Biomark 2006; 2(6): 219-34.
19. Holmes WF, Braastad CD, Mitra P etal. Coordinate control and selective expression of the full complement of replication-dependent histone H4 genes in normal and cancer cells. J Biol Chem 2005; 280: 37400-07.
20. Jaskelioff M, Peterson CL. Chromatin and transcription: Histones continue to make their marks. Nat Cell Biol 2003; 5(5): 395-9.
21. Breen EC, Tang K. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 2003; 88: 848-54.
22. De Petris L, Orre LM, Kanter L etal. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. Lung Cancer 2009; 63(3): 410-17.
23. Joo JH, Yoon SH, Kim JH etal. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J Cell Biochem 2008; 103(4): 1183-97.
24. Chilosi M, Murer B. Mixed adenocarcinomas of the lung: Place in new proposals in classification, mandatory for target therapy. Arch Pathol Lab Med 2010; 134(1): 55-65.
25. Terry J, Leung S, Laskin J etal. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol 2010; 34(12): 1805-11.